Intraocular lens
Latest Santen Pharmaceutical Co., Ltd. Patents:
- Medicament comprising combination of sepetaprost and Rho-associated coiled-coil containing protein kinase inhibitor
- AGENT FOR TREATING OR PREVENTING GLAUCOMA INCLUDING A SULFONAMIDE COMPOUND AND ANOTHER DRUG
- Medicament for preventing and/or treating dry eye
- Agent for treating or preventing glaucoma including a sulfonamide compound and another drug
- Therapeutic agent for meibomian dysfunction
Description
The Broken line showings of
The dashed-dotted line showings of
Claims
The ornamental design for an intraocular lens, as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
4435855 | March 13, 1984 | Pannu |
5217490 | June 8, 1993 | Sayano et al. |
5217491 | June 8, 1993 | Vanderbilt |
5326506 | July 5, 1994 | Vanderbilt |
5716403 | February 10, 1998 | Tran et al. |
5725574 | March 10, 1998 | Nguyen |
D395512 | June 23, 1998 | Korenfeld |
5840219 | November 24, 1998 | Nguyen |
6488709 | December 3, 2002 | Barrett |
7615073 | November 10, 2009 | Deacon et al. |
7621949 | November 24, 2009 | Deacon et al. |
7794497 | September 14, 2010 | Brady et al. |
7837730 | November 23, 2010 | Cumming et al. |
- U.S. Appl. No. 12/954,424, filed Nov. 24, 2010, Doraiswamy et al.
- U.S. Appl. No. 12/955,654, filed Nov. 29, 2010, Doraiswamy et al.
Patent History
Patent number: D691273
Type: Grant
Filed: Sep 6, 2011
Date of Patent: Oct 8, 2013
Assignee: Santen Pharmaceutical Co., Ltd. (Osaka-Shi, Osaka)
Inventors: Anand Doraiswamy (Goleta, CA), Jensen Buck (Goleta, CA), Daniel Hamilton (Emeryville, CA)
Primary Examiner: Randall Gholson
Application Number: 29/401,065
Type: Grant
Filed: Sep 6, 2011
Date of Patent: Oct 8, 2013
Assignee: Santen Pharmaceutical Co., Ltd. (Osaka-Shi, Osaka)
Inventors: Anand Doraiswamy (Goleta, CA), Jensen Buck (Goleta, CA), Daniel Hamilton (Emeryville, CA)
Primary Examiner: Randall Gholson
Application Number: 29/401,065
Classifications
Current U.S. Class:
Ocular (D24/157)